Evaluating the Cost-effectiveness of Realistic Screening Interventions Across Sev

评估跨部门的现实筛查干预措施的成本效益

• 批准号: 8434966
• 负责人: David B Rein
• 金额: $ 5.99万
• 依托单位: NATIONAL OPINION RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2014-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8434966
• 关键词: Evaluating; Cost; effectiveness; Realistic; Screening

DESCRIPTION (provided by applicant): Evaluating the cost-effectiveness of ophthalmologic screening initiatives can guide decisions about when and where to implement screening. If done well, these analyses can help target scarce visual health resources in a way that maximizes societal well-being at a reasonable cost. The need for targeted visual health screening in the United States is increasing as the U.S. population ages because the epidemiology of major adult visual disorders is age-related. However, assessing the cost-effectiveness of visual screening is complicated by subpopulation differences in the routine use of visual screening services. Models that fail to account for this heterogeneity may lead to erroneous conclusions about where and when screening services are justified. In Aim 1 of this project, we will make substantial improvements to an existing visual health simulation model that will enable it to account for heterogeneous patient screening histories based on empirically observed patient data from the Beaver Dam Eye Study and the Los Angeles Latino Eye Study. The model will be unique in at least three important respects: (1) it will be the only cost-effectiveness model that includes the benefits of preventing multiple eye diseases with a single screening intervention; (2) it will be the only visual health screening model that evaluates the cost-effectiveness of a visual health screening intervention implemented in a realistic, mixed-age group population; and (3) it will be the only visual health model that incorporates real patient data at the individual level, which enables the model to simulate the benefit of screening among a mixed group of heterogeneous patients. In Aim 2, we will use the improved model to estimate the cost-effectiveness of visual health screening interventions when considering the benefits of preventing multiple eye diseases and accounting for patient differences in past service use, insurance coverage, and costs to screen. Finally, in Aim 3, we will use the results from our cost-effectiveness analyses to develop a user-friendly software tool that will enable findings to be disseminated to a wide range of decision makers, practitioners, and researchers in a way that is most meaningful in their individual setting. If successful, the project as a whole could lead to improvements in the targeting of visual health screening services and enhancements to the public welfare at a reasonable cost.

描述（由申请人提供）：评估眼科筛查计划的成本效益可以指导何时何地实施筛查的决定。如果做得好，这些分析可以帮助以合理的成本最大化社会福祉的方式瞄准稀缺的视觉健康资源。随着美国人口的老龄化，美国对有针对性的视觉健康筛查的需求正在增加，因为主要成人视觉障碍的流行病学与年龄有关。然而，评估视力筛查的成本效益是复杂的亚群差异，在常规使用视力筛查服务。未能解释这种异质性的模型可能会导致错误的结论，即在何处以及何时进行筛查服务是合理的。在本项目的目标1中，我们将对现有的视觉健康模拟模型进行实质性改进，使其能够根据比弗坝眼科研究和洛杉矶拉丁裔眼科研究的经验观察患者数据解释异质性患者筛查历史。该模型至少在三个重要方面是独一无二的：（1）它将是唯一的成本效益模型，包括通过单一筛查干预措施预防多种眼疾的好处;（2）它将是唯一的视觉健康筛查模型，评估在现实的混合年龄组人群中实施视觉健康筛查干预措施的成本效益;以及（3）它将是唯一在个体水平上结合真实的患者数据的视觉健康模型，这使得该模型能够模拟在异质患者的混合组中进行筛查的益处。在目标2中，我们将使用改进的模型来估计视觉健康筛查干预措施的成本效益，同时考虑预防多种眼病的益处，并考虑患者在过去服务使用、保险范围和筛查成本方面的差异。最后，在目标3中，我们将利用成本效益分析的结果开发一个用户友好的软件工具，使研究结果能够以最有意义的方式传播给广泛的决策者、从业者和研究人员。如果成功，该项目作为一个整体可以以合理的成本改善视觉健康筛查服务的针对性并增强公共福利。

项目成果

The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.

• DOI: 10.1111/j.1475-6773.2011.01263.x
• 发表时间: 2011-10
• 期刊: Health services research
• 影响因子: 3.4
• 作者: Rein DB;Wittenborn JS;Zhang X;Allaire BA;Song MS;Klein R;Saaddine JB;Vision Cost-Effectiveness Study Group
• 通讯作者: Vision Cost-Effectiveness Study Group

Attributes associated with eye care use in the United States: a meta-analysis.

• DOI: 10.1016/j.ophtha.2012.12.030
• 发表时间: 2013-07
• 期刊: Ophthalmology
• 影响因子: 13.7
• 作者: Wagner LD;Rein DB
• 通讯作者: Rein DB

Cost-effectiveness of glaucoma interventions in Barbados and Ghana.

• DOI: 10.1097/opx.0b013e3181fc30f3
• 发表时间: 2011-01
• 期刊: Optometry and vision science : official publication of the American Academy of Optometry
• 作者: Wittenborn JS;Rein DB
• 通讯作者: Rein DB